Zoetis Inc. shows promising fundamentals in the animal healthcare sector. Its diversified product portfolio across different species and strong market presence provide a robust competitive edge. Current market conditions suggest solid growth potential despite certain risk exposures.
Zoetis Inc. holds a strong fundamental rating. Its financial metrics reveal a balance of profitability and valuation efficiency.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return On Equity | 5 | |
| Return On Assets | 5 | |
| Debt To Equity | 3 | |
| Price To Earnings | 2 | |
| Price To Book | 1 |
Tracking historical scores helps assess the company's rating dynamics over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-11-28 | 4 | 4 | 5 | 5 | 3 | 2 | 1 |
| 2025-11-29 | 4 | 4 | 5 | 5 | 3 | 2 | 1 |
Analyst estimates suggest a positive price trend for Zoetis Inc., with potential for considerable returns.
| High | Low | Median | Consensus |
|---|---|---|---|
| $215 | $140 | $158 | $171 |
The overall sentiment from analysts is generally favorable towards Zoetis Inc., reflecting confidence in its growth potential.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 16 | |
| Hold | 13 | |
| Sell | 0 | |
| Strong Sell | 0 |
Zoetis Inc. presents a promising investment opportunity, bolstered by its strong fundamental rating and positive analyst sentiments. The company is well-positioned in the animal healthcare industry with robust vaccination and pharmaceutical offerings. However, potential investors should be cautious of sector-specific risks and market volatility. Overall, Zoetis Inc. is set for future growth with strategic expertise in both companion and livestock animal markets.